Category : Seeking Alpha

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

3 hours from now
Collegium Announces $25 Million Accelerated Share Repurchase Program

3 hours from now
Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025

3 hours from now
Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040

3 hours from now
Longevity Health Holdings, Inc. Announces Reverse Stock Split

3 hours from now